J&J Unit Escapes FCA Case Over Alleged Procrit Kickbacks

Law360, New York (August 14, 2012, 1:25 PM EDT) -- A biotechnology unit of Johnson & Johnson on Monday dispensed with the remnants of a False Claims Act case alleging kickbacks to doctors who prescribed anemia drug Procrit after the relator conceded she lacked evidence to support the few allegations left intact after years of litigation.

U.S. District Judge Rya W. Zobel two years ago sharply limited the scope of the case, pointing out that account specialist Mark Duxbury had been fired in 1998 and that the complaint wasn’t filed until 2003. Because the False Claims...
To view the full article, register now.




Case Information

Case Title

United States of America, v. Duxbury et al

Case Number




Nature of Suit

Other Statutory Actions


Rya W. Zobel

Date Filed

November 5, 2003

Law Firms


UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.